BioCentury
ARTICLE | Finance

Tysabri chronicles

June 12, 2006 7:00 AM UTC

Biogen Idec's stock moves have been less volatile than those of Elan following good or bad news related to their Tysabri MS drug. The reason is BIIB is more insulated - the company is profitable. Even...